Pragmatic reappraisal of long-acting muscarinic antagonists at steps 4 and 5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology

Brian Lipworth; Kirsten Stewart; Rory Chan

doi:10.1016/j.anai.2022.05.017

Pragmatic reappraisal of long-acting muscarinic antagonists at steps 4 and 5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology

Brian Lipworth (Lead / Corresponding author), Kirsten Stewart, Rory Chan

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

75 Downloads (Pure)

Original language	English
Pages (from-to)	274-275
Number of pages	2
Journal	Annals of Allergy, Asthma and Immunology
Volume	129
Issue number	3
Early online date	22 May 2022
DOIs	https://doi.org/10.1016/j.anai.2022.05.017
Publication status	Published - Sept 2022

Keywords

ong acting muscarinic antagonist
long acting beta-agonist
inhaled corticosteroid
triple inhaler
asthma exacerbations
asthma control Abbreviations AER: annualised exacerbation rate
COPD: chronic obstructive pulmonary disease
FeNO: fractional exhaled breath nitric oxide
FEV1: forced expiratory volume in 1s
GINA: global initiative for asthma
ICS: inhaled corticosteroid
LABA: long acting beta-agonist
LAMA: long acting muscarinic antagonist
Ppb: parts per billion
TTT: time to treat to prevent an exacerbation

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine
Immunology and Allergy
Immunology

Access to Document

10.1016/j.anai.2022.05.017Licence: CC BY

Final published versionFinal published version, 254 KBLicence: CC BY

Cite this

@article{88b5c5f5957d4805b9c13b5029856303,

title = "Pragmatic reappraisal of long-acting muscarinic antagonists at steps 4 and 5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology",

keywords = "ong acting muscarinic antagonist, long acting beta-agonist, inhaled corticosteroid, triple inhaler, asthma exacerbations, asthma control Abbreviations AER: annualised exacerbation rate, COPD: chronic obstructive pulmonary disease, FeNO: fractional exhaled breath nitric oxide, FEV1: forced expiratory volume in 1s, GINA: global initiative for asthma, ICS: inhaled corticosteroid, LABA: long acting beta-agonist, LAMA: long acting muscarinic antagonist, Ppb: parts per billion, TTT: time to treat to prevent an exacerbation",

author = "Brian Lipworth and Kirsten Stewart and Rory Chan",

year = "2022",

month = sep,

doi = "10.1016/j.anai.2022.05.017",

language = "English",

volume = "129",

pages = "274--275",

journal = "Annals of Allergy, Asthma and Immunology",

issn = "1081-1206",

publisher = "American College of Allergy, Asthma and Immunology",

number = "3",

}

Pragmatic reappraisal of long-acting muscarinic antagonists at steps 4 and 5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology. / Lipworth, Brian (Lead / Corresponding author); Stewart, Kirsten ; Chan, Rory.
In: Annals of Allergy, Asthma and Immunology, Vol. 129, No. 3, 09.2022, p. 274-275.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Pragmatic reappraisal of long-acting muscarinic antagonists at steps 4 and 5 for persistent adult asthma

T2 - Invited Perspective article for Annals of Allergy, Asthma and Immunology

AU - Lipworth, Brian

AU - Stewart, Kirsten

AU - Chan, Rory

PY - 2022/9

Y1 - 2022/9

KW - ong acting muscarinic antagonist

KW - long acting beta-agonist

KW - inhaled corticosteroid

KW - triple inhaler

KW - asthma exacerbations

KW - asthma control Abbreviations AER: annualised exacerbation rate

KW - COPD: chronic obstructive pulmonary disease

KW - FeNO: fractional exhaled breath nitric oxide

KW - FEV1: forced expiratory volume in 1s

KW - GINA: global initiative for asthma

KW - ICS: inhaled corticosteroid

KW - LABA: long acting beta-agonist

KW - LAMA: long acting muscarinic antagonist

KW - Ppb: parts per billion

KW - TTT: time to treat to prevent an exacerbation

UR - http://www.scopus.com/inward/record.url?scp=85132701890&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2022.05.017

DO - 10.1016/j.anai.2022.05.017

M3 - Article

C2 - 35613664

SN - 1081-1206

VL - 129

SP - 274

EP - 275

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

IS - 3

ER -

Pragmatic reappraisal of long-acting muscarinic antagonists at steps 4 and 5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this